Cgmp medicine manufacturing: a prototype for a distributed network (AKA production of cisatracurium drug substance (API) and drug product)
Ended Other Transaction Agreement Awarded Last action
- Contract number
- N000142492002
- Awardee
-
On Demand Pharmaceuticals Inc. UEI SN3RFJHJ2GP3
- Awarding agency
-
Office of Naval Research
Secretary of the Navy, Department of Defense
- Obligated
- $16,251,843
Award facts
- Opportunity
-
- FY24 Long Range BAA Solicitation · N0001424SB001 · Posted Oct 2, 2023
- Contract value 100% obligated
- $16,251,843.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Office of the Assistant Secretary for Preparedness and Response Department of Health and Human Services
- NAICS code
- Not on record
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$442 | |
| Supplemental Agreement for work within scope | -$2,747,715 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $19,000,000 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded an Other Transaction Agreement to On Demand Pharmaceuticals Inc. on June 1, 2024, with a ceiling value of $16,251,843 for a prototype distributed network manufacturing cisatracurium drug substance (API) and drug product under current good manufacturing practice (CGMP) standards. This OTA sits outside the FAR and operates under the statutory authorities that govern Other Transaction Agreements.
The effort focuses on developing a distributed manufacturing network capable of producing critical pharmaceutical intermediates and active pharmaceutical ingredients through flexible, point-of-care manufacturing technologies. Place of performance is Rockville, Maryland. The ultimate completion date is May 19, 2026.
The underlying solicitation was a Broad Agency Announcement posted by the Office of Naval Research on October 2, 2023, seeking proposals for long-range science and technology projects with potential to advance Navy and Marine Corps operations. The BAA carried no set-aside designation and was open to all contractors, with a proposal due date of September 30, 2024. On Demand Pharmaceuticals Inc. is a for-profit entity registered in SAM.gov, specializing in advanced pharmaceutical manufacturing and research solutions with emphasis on distributed and adaptable manufacturing systems for critical medical compounds.
Quick answers
Who was awarded contract N000142492002?
N000142492002 was awarded to On Demand Pharmaceuticals Inc. by Office of Naval Research (Secretary of the Navy) on June 1, 2024.
How much is contract N000142492002 worth?
The government has obligated $16,251,843 on N000142492002.
Which agency awarded contract N000142492002?
Office of Naval Research (Secretary of the Navy) awarded N000142492002, with funding from Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services).
Was contract N000142492002 competed?
The extent of competition for N000142492002 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award